The COVID-19 booster in 2025 is recommended primarily for those at higher risk of serious illness from COVID-19. This includes:
- Adults aged 75 years and older
- Residents in care homes for older adults
- Individuals aged 6 months and over who are immunosuppressed due to health conditions or treatments
This targeted vaccination approach focuses on protecting people most vulnerable to severe outcomes. The booster is typically offered about 6 months after the last vaccine dose. For those eligible, receiving the booster can help maintain protection against severe disease, hospitalization, and death from COVID-19.
In the United States, the CDC recommends the 2024-2025 COVID-19 vaccine for most adults 18 and older, with special emphasis on those 65 and older, people at high risk for severe COVID-19, immunocompromised individuals, and residents of long-term care facilities. Parents of children aged 6 months to 17 years should consult healthcare providers for vaccination decisions. The vaccine protects against severe illness and is updated to address current viral strains.
In summary, COVID-19 boosters in 2025 should be received by older adults (75+), care home residents, and immunocompromised individuals, while others at high risk or those seeking extra protection should consult health guidance.
